Transcranial Ultrasound (TUS) Effects on Mental States: a Pilot Study
Overview
Authors
Affiliations
Background/objective: Transcranial ultrasound (TUS) can modulate brain function. To assess possible TUS modulation of mental states, we investigated effects on subjective reports of pain and mood of sub-thermal TUS versus placebo applied to frontal scalp and brain of chronic pain patient volunteers.
Methods: With IRB approval and informed consent, subjects with chronic pain completed two visual analog scales for pain (NRS) and mood (VAMS/Global Affect), and their vital signs were recorded 10 min prior to, and 10 min and 40 min following exposure to either subthermal TUS (8 MHz) or placebo (in a double blind crossover study) using the 12L-RS probe of a LOGIQe ultrasound imaging machine (General Electric, USA). A physician, also blinded for TUS versus placebo, applied the probe (with gel) to scalp over posterior frontal cortex, contralateral to maximal pain, for 15 seconds. A second investigator operated the ultrasound machine, randomizing TUS versus placebo. The process was then repeated, applying the opposite modality (TUS or placebo).
Results: Subjective reports of Mood/Global Affect were improved 10 min (P = 0.03) and 40 min (P = 0.04) following TUS compared with placebo. NRS pain reports slightly improved following TUS (P = 0.07) at 40 min.
Conclusion: We found improvement in subjective mood 10 min and 40 min after TUS compared to placebo. TUS can have safe neurophysiological effects on brain function, and is a promising noninvasive therapy for modulating conscious and unconscious mental states and disorders. We suggest TUS acts via intra-neuronal microtubules, which apparently resonate in TUS megahertz range.
Kim M, Yeh C, Yu K, Li Z, Gupta K, He B APL Bioeng. 2025; 9(1):016108.
PMID: 39990925 PMC: 11846022. DOI: 10.1063/5.0236108.
Shen Y, Jethe J, Reid A, Hehir J, Amaral M, Ren C Commun Biol. 2025; 8(1):12.
PMID: 39762513 PMC: 11704147. DOI: 10.1038/s42003-024-07356-2.
Gatica M, Atkinson-Clement C, Mediano P, Alkhawashki M, Ross J, Sallet J Netw Neurosci. 2024; 8(4):1032-1050.
PMID: 39735508 PMC: 11674579. DOI: 10.1162/netn_a_00388.
The therapeutic potential of low-intensity focused ultrasound for treating substance use disorder.
Olaitan G, Lynch W, Venton B Front Psychiatry. 2024; 15:1466506.
PMID: 39628494 PMC: 11612502. DOI: 10.3389/fpsyt.2024.1466506.
Dynamic changes in human brain connectivity following ultrasound neuromodulation.
Atkinson-Clement C, Alkhawashki M, Gatica M, Ross J, Kaiser M Sci Rep. 2024; 14(1):30025.
PMID: 39627315 PMC: 11614892. DOI: 10.1038/s41598-024-81102-w.